PVP-coated silver nanoparticles showing antifungal improved activity against dermatophytes

Journal of Nanoparticle Research

Volumn 16, Issue 11, 2014, Pages

  Silva, Edgar ^a   Saraiva, Sofia ^a   Miguel, Sónia ^a   Correia, Ilídio J ^a  

^a UNIVERSITY OF BEIRA INTERIOR   (Portugal)

Author keywords

Biocompatibility; Fungal infections; Polyvinylpyrrolidone; Silver nanoparticles

Indexed keywords

BIOCOMPATIBILITY; ENERGY DISPERSIVE SPECTROSCOPY; FUNGI; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; LIGHT SCATTERING; METAL NANOPARTICLES;

ANTI-FUNGAL ACTIVITY; ANTI-MICROBIAL PROPERTIES; ENERGY DISPERSIVE X RAY SPECTROSCOPY; FOURIER TRANSFORM INFRA REDS; FUNGAL INFECTION; IMPROVED ACTIVITIES; MICROBIAL RESISTANCE; POLY VINYL PYRROLIDONE;

SILVER NANOPARTICLES;

POVIDONE; SILVER NANOPARTICLE;

ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DERMATOPHYTE; FOURIER TRANSFORMATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIGHT SCATTERING; MYCOSIS; ROENTGEN SPECTROSCOPY; SKIN INFECTION; TRANSMISSION ELECTRON MICROSCOPY; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON RUBRUM; X RAY DIFFRACTION;

EID: 84912544562     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-014-2726-2     Document Type: Article

References (75)

1. Agnihotri S, Mukherji S, Mukherji S (2012) Antimicrobial chitosan–PVA hydrogel as a nanoreactor and immobilizing matrix for silver nanoparticles. Appl Nanosci 2:179–188
2. Aguilar-Méndez MA, Martín-Martínez ES, Ortega-Arroyo L, Cobián-Portillo G, Sánchez-Espíndola E (2011) Synthesis and characterization of silver nanoparticles: effect on phytopathogen Colletotrichum gloesporioides. J Nanoparticle Res 13:2525–2532
3. Ahamed M, Karns M, Goodson M, Rowe J, Hussain SM, Schlager JJ, Hong Y (2008) DNA damage response to different surface chemistry of silver nanoparticles in mammalian cells. Toxicol Appl Pharmacol 233:404–410
4. AshaRani P, Low Kah Mun G, Hande MP, Valiyaveettil S (2008) Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS nano 3:279–290
5. Badawy AME, Luxton TP, Silva RG, Scheckel KG, Suidan MT, Tolaymat TM (2010) Impact of environmental conditions (pH, ionic strength, and electrolyte type) on the surface charge and aggregation of silver nanoparticles suspensions. Environ Sci Technol 44:1260–1266
6. Baldo A et al (2012) Mechanisms of skin adherence and invasion by dermatophytes. Mycoses 55:218–223
7. Brigger I, Dubernet C, Couvreur P (2002) Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev 54:631–651
8. Bryaskova R, Pencheva D, Nikolov S, Kantardjiev T (2011) Synthesis and comparative study on the antimicrobial activity of hybrid materials based on silver nanoparticles (AgNps) stabilized by polyvinylpyrrolidone (PVP). J chem biol 4:185–191
9. Charles AJ (2009) Superficial cutaneous fungal infections in tropical countries. Dermatol Ther 22:550–559
10. Chen M, Yang Z, Wu H, Pan X, Xie X, Wu C (2011) Antimicrobial activity and the mechanism of silver nanoparticle thermosensitive gel. Int J Nanomedicine 6:2873–2877
11. Clinical and Laboratory Standards Institute (CLSI) (2008) Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard, Second Edition M38-A2 edn., Wayne
12. Crawford F, Hollis S (2007) Topical treatments for fungal infections of the skin and nails of the foot. Cochrane Database Syst Rev 3:1–118
13. Csempesz F, Csáki KF (2000) Mixed adsorption layers of uncharged polymers at particle/solution interfaces. Langmuir 16:5917–5920
14. da Silva Barros ME, de Santos DA, Hamdan JS (2007) Evaluation of susceptibility of Trichophyton mentagrophytes and Trichophyton rubrum clinical isolates to antifungal drugs using a modified CLSI microdilution method (M38-A). J med microbiol 56:514–518
15. de Souza ALR, Kiill CP, dos Santos FK, da Luz GM, e Silva HR, Chorilli M, Gremiao MPD (2012) Nanotechnology-based drug delivery systems for dermatomycosis treatment. Curr Nanosci 8:512–519
16. Deivaraj T, Lala NL, Lee JY (2005) Solvent-induced shape evolution of PVP protected spherical silver nanoparticles into triangular nanoplates and nanorods. J Colloid Interface Sci 289:402–409
17. Dong PV, Ha CH, Kasbohm J (2012) Chemical synthesis and antibacterial activity of novel-shaped silver nanoparticles. Int Nano Lett 2:1–9
18. Gaspar V, Sousa F, Queiroz J, Correia I (2011a) Formulation of chitosan–TPP–pDNA nanocapsules for gene therapy applications. Nanotechnology 22:015101
19. Gaspar VM, Correia IJ, Sousa Â, Silva F, Paquete CM, Queiroz JA, Sousa F (2011b) Nanoparticle mediated delivery of pure P53 supercoiled plasmid DNA for gene therapy. J Controll Release 156:212–222
20. Ghannoum M, Chaturvedi V, Espinel-Ingroff A, Pfaller M, Rinaldi M, Lee-Yang W, Warnock D (2004) Intra-and interlaboratory study of a method for testing the antifungal susceptibilities of dermatophytes. J Clin Microbiol 42:2977–2979
21. Guinier A (2013) X-ray diffraction: in crystals, imperfect crystals, and amorphous bodies. Courier Dover Publications, New York
22. Gupta AK, Cooper EA (2008) Update in antifungal therapy of dermatophytosis. Mycopathologia 166:353–367
23. Havlickova B, Czaika VA, Friedrich M (2008) Epidemiological trends in skin mycoses worldwide. Mycoses 51:2–15
24. Hussain JI, Kumar S, Hashmi AA, Khan Z (2011) Silver nanoparticles: preparation, characterization, and kinetics advanced. Mater Lett 2:188–194
25. Kim K-J, Sung WS, Moon S-K, Choi J-S, Kim JG, Lee DG (2008) Antifungal effect of silver nanoparticles on dermatophytes. J Microbiol Biotechnol 18:1482–1484
26. Kim K-J, Sung WS, Suh BK, Moon S-K, Choi J-S, Kim JG, Lee DG (2009) Antifungal activity and mode of action of silver nano-particles on Candida albicans. Biometals 22:235–242
27. Krishnaraj C, Ramachandran R, Mohan K, Kalaichelvan P (2012) Optimization for rapid synthesis of silver nanoparticles and its effect on phytopathogenic fungi. Spectrochim Acta Part A 93:95–99
28. Kvitek L et al (2008) Effect of surfactants and polymers on stability and antibacterial activity of silver nanoparticles (NPs). J Phys Chem C 112:5825–5834
29. Larese FF, D’Agostin F, Crosera M, Adami G, Renzi N, Bovenzi M, Maina G (2009) Human skin penetration of silver nanoparticles through intact and damaged skin. Toxicology 255:33–37
30. Lee J, Kim K-J, Sung WS, Kim JG, Lee DG (2010) The silver nanoparticle (nano-Ag): a new model for antifungal agents Silver Nanoparticles Rijeka, Croatia: INTECH:295–308
31. Levard C, Hotze EM, Lowry GV, Brown GE Jr (2012) Environmental transformations of silver nanoparticles: impact on stability and toxicity. Environ Sci Technol 46:6900–6914
32. Li G, Wen Q, Zhang T, Ju Y (2013) Synthesis and properties of silver nanoparticles in chitosan-based thermosensitive semi-interpenetrating hydrogels. J Appl Polym Sci 127:2690–2697
33. Lok C-N et al (2007) Silver nanoparticles: partial oxidation and antibacterial activities JBIC. J Biol Inorg Chem 12:527–534
34. Longmire M, Choyke PL, Kobayashi H (2008) Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine 3:703–717
35. Marcato PD, Duran M, Huber SC, Rai M, Melo PS, Alves OL, Duran N (2012) Biogenic silver nanoparticles and its antifungal activity as a new topical transungual drug. J Nano Res 20:99–107
36. Miguel SP, Ribeiro MP, Brancal H, Coutinho P, Correia IJ (2014) Thermoresponsive chitosan-agarose hydrogel for skin regeneration. Carbohydr Polym 111:366–373
37. Mijnendonckx K, Leys N, Mahillon J, Silver S, Van Houdt R (2013) Antimicrobial silver: uses, toxicity and potential for resistance. Biometals 26:609–621
38. Monteiro DR, Gorup LF, Takamiya AS, Ruvollo-Filho AC, Camargo ERD, Barbosa DB (2009) The growing importance of materials that prevent microbial adhesion: antimicrobial effect of medical devices containing silver. Int J Antimicrob Agents 34:103–110
39. Moriarty B, Hay R, Morris-Jones R (2012) The diagnosis and management of tinea. BMJ 345:37–42
40. Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, Ramírez JT, Yacaman MJ (2005) The bactericidal effect of silver nanoparticles. Nanotechnology 16:2346
41. Naik RR, Stringer SJ, Agarwal G, Jones SE, Stone MO (2002) Biomimetic synthesis and patterning of silver nanoparticles. Nat Mater 1:169–172
42. Nguyen VH, Kim B-K, Jo Y-L, Shim J-J (2012) Preparation and antibacterial activity of silver nanoparticles-decorated graphene composites. J Supercrit Fluids 72:28–35
43. Noorbakhsh F, Rezaie S, Shahverdi AR (2011) Antifungal effects of silver nanoparticle alone and with combination of antifungal drug on dermatophyte pathogen Trichophyton rubrum. In: International conference on bioscience, biochemistry and bioinformatics 1:264–267
44. Odom R (1993) Pathophysiology of dermatophyte infections. J Am Acad Dermatol 28:S2–S7
45. Okeke C, Tsuboi R, Kawai M, Ogawa H (2000) Fluorometric assessment of in vitro antidermatophytic activities of antimycotics based on their keratin-penetrating power. J Clin Microbiol 38:489–491
46. Panáček A et al (2009) Antifungal activity of silver nanoparticles against Candida spp. Biomaterials 30:6333–6340
47. Pastoriza-Santos I, Liz-Marzán LM (2002) Formation of PVP-protected metal nanoparticles in DMF. Langmuir 18:2888–2894
48. Perán M, García MA, Lopez-Ruiz E, Jiménez G, Marchal JA (2013) How can nanotechnology help to repair the body? advances in cardiac, skin, bone, cartilage and nerve tissue regeneration. Materials 6:1333–1359
49. Puchalski M, Dąbrowski P, Olejniczak W, Krukowski P, Kowalczyk P, Polański K (2007) The study of silver nanoparticles by scanning electron microscopy, energy dispersive X-ray analysis and scanning tunnelling microscopy. Mater Sci 0137–1339:25
50. Rai M, Yadav A, Gade A (2009) Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv 27:76–83
51. Rathod V, Banu A, Ranganath E (2012) Biosynthesis of highly stabilized silver nanoparticles by Rhizopus stolonifer and their anti-fungal efficacy. Int J Cur Biomed Phar Res 2:241–245
52. Ravindran A, Chandran P, Khan SS (2013) Biofunctionalized silver nanoparticles: advances and prospects. Colloids Surf, B 105:342–352
53. Ribeiro MP et al (2009) Development of a new chitosan hydrogel for wound dressing. Wound Repair Regen 17:817–824
54. Ribeiro M, Morgado P, Miguel S, Coutinho P, Correia I (2013) Dextran-based hydrogel containing chitosan microparticles loaded with growth factors to be used in wound healing. Mater Sci Eng, C 33:2958–2966
55. Ruparelia JP, Chatterjee AK, Duttagupta SP, Mukherji S (2008) Strain specificity in antimicrobial activity of silver and copper nanoparticles. Acta Biomater 4:707–716
56. Samberg ME, Oldenburg SJ, Monteiro-Riviere NA (2010) Evaluation of silver nanoparticle toxicity in skin in vivo and keratinocytes in vitro. Environ Health Perspect 118:407
57. Seoudi R, Shabaka A, El Sayed Z, Anis B (2011) Effect of stabilizing agent on the morphology and optical properties of silver nanoparticles. Physica E 44:440–447
58. Sharma VK, Yngard RA, Lin Y (2009) Silver nanoparticles: green synthesis and their antimicrobial activities. Adv Colloid Interface Sci 145:83–96
59. Singh AK, Raykar VS (2008) Microwave synthesis of silver nanofluids with polyvinylpyrrolidone (PVP) and their transport properties. Colloid Polym Sci 286:1667–1673
60. Singh M, Kumar M, Kalaivani R, Manikandan S, Kumaraguru A (2013) Metallic silver nanoparticle: a therapeutic agent in combination with antifungal drug against human fungal pathogen. Bioprocess Biosyst Eng 36:407–415
61. Sondi I, Salopek-Sondi B (2004) Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci 275:177–182
62. Sondi I, Goia DV, Matijević E (2003) Preparation of highly concentrated stable dispersions of uniform silver nanoparticles. J Colloid Interface Sci 260:75–81
63. Song KC, Lee SM, Park TS, Lee BS (2009) Preparation of colloidal silver nanoparticles by chemical reduction method. Korean J Chem Eng 26:153–155
64. Stoimenov PK, Klinger RL, Marchin GL, Klabunde KJ (2002) Metal oxide nanoparticles as bactericidal agents. Langmuir 18:6679–6686
65. Suresh AK, Pelletier DA, Wang W, Morrell-Falvey JL, Gu B, Doktycz MJ (2012) Cytotoxicity induced by engineered silver nanocrystallites is dependent on surface coatings and cell types. Langmuir 28:2727–2735
66. Tejamaya M, Römer I, Merrifield RC, Lead JR (2012) Stability of citrate, PVP, and PEG coated silver nanoparticles in ecotoxicology media. Environ Sci Technol 46:7011–7017
67. Venkatakrishnan K, von Moltke LL, Greenblatt DJ (2000) Effects of the antifungal agents on oxidative drug metabolism. Clin Pharmacokinet 38:111–180
68. Wilhelm C, Billotey C, Roger J, Pons J, Bacri J-C, Gazeau F (2003) Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating. Biomaterials 24:1001–1011
69. Xu Y, Gao C, Li X, He Y, Zhou L, Pang G, Sun S (2013) In vitro antifungal activity of silver nanoparticles against ocular pathogenic filamentous fungi. J Ocul Pharmacol Ther 29:270–274
70. Yu H, Xu X, Chen X, Lu T, Zhang P, Jing X (2007) Preparation and antibacterial effects of PVA–PVP hydrogels containing silver nanoparticles. J Appl Polym Sci 103:125–133
71. Zhang Z, Zhao B, Hu L (1996) PVP protective mechanism of ultrafine silver powder synthesized by chemical reduction processes. J Solid State Chem 121:105–110
72. Zhang Q, Li N, Goebl J, Lu Z, Yin Y (2011) A systematic study of the synthesis of silver nanoplates: is citrate a “magic” reagent? J Am Chem Soc 133:18931–18939
73. Zhao T, Sun R, Yu S, Zhang Z, Zhou L, Huang H, Du R (2010) Size-controlled preparation of silver nanoparticles by a modified polyol method. Colloids Surf, A 366:197–202
74. Zhou Y, Kong Y, Kundu S, Cirillo JD, Liang H (2012) Antibacterial activities of gold and silver nanoparticles against Escherichia coli and bacillus Calmette–Guérin. J NanoBiotechnol 10:19
75. Zielińska A, Skwarek E, Zaleska A, Gazda M, Hupka J (2009) Preparation of silver nanoparticles with controlled particle size. Procedia Chem 1:1560–1566